Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Incidence of Hepatitis B Virus (HBV) Reactivation in HBsAg Negative/HBcAb Positive Lymphoma Patients Treated With RCHOP (IHBVRL)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2014 by Fudan University.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Junning Cao, Fudan University
ClinicalTrials.gov Identifier:
NCT01210287
First received: September 27, 2010
Last updated: January 7, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2014
  Estimated Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)